Results 231 to 240 of about 76,819 (327)

New therapeutic concepts in bile acid transport and signaling for management of cholestasis

Hepatology, 2017
M. Trauner, C. Fuchs, E. Halilbasic, G. Paumgartner   +3 more
semanticscholar   +1 more source

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

Nutrition in Clinical Practice, Volume 40, Issue 4, Page 816-828, August 2025.
Abstract Cystic fibrosis transmembrane regulator (CFTR)–directed therapies, such as modulators, have transformed the medical management of people with CF, resulting in better lung function, weight, and body mass index in recent years. With improved nutrition status in people on CFTR modulators, the emphasis on a high‐energy, high‐fat diet (the legacy ...
Kay Vavrina, Tara B. Griffin, Angel M. Jones, Terri Schindler, Trang N. Bui, Senthilkumar Sankararaman   +5 more
wiley   +1 more source

Severe neonatal cholestasis in <i>HNF1β</i> deficiency: a case report and literature review. [PDF]

Front Pediatr
Gagliano C, Burattini O, Paradisi L, Recchione S, Santoro L, Caponi L, Ciaschini A, Lionetti ME, Gatti S.   +8 more
europepmc   +1 more source

Transplantation of Severely Steatotic Liver Grafts After Machine Perfusion Remains a Risky Challenge

Clinical Transplantation, Volume 39, Issue 8, August 2025.
ABSTRACT Liver transplantation is the treatment of choice for patients with end‐stage liver disease. However, donor shortages have increased the use of high‐risk and extended criteria donor livers, including livers donated after circulatory death and those with severe steatosis.
Riccardo Cirelli, Adam M. Thorne, Otto B. van Leeuwen, Bianca Lascaris, Veerle A. Lantinga, Silke B. Bodewes, Marius C. van den Heuvel, Robert J. Porte, Vincent E. de Meijer   +8 more
wiley   +1 more source

A sporadic case of benign recurrent intrahepatic cholestasis in a growth-impaired young male. [PDF]

Sci Prog
Shao J, Fan R, Shao M, Dai M, Huang G, Guo Q, Cao L.   +6 more
europepmc   +1 more source

Glucagon‐like peptide 1 (GLP‐1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials

Diabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4102-4108, August 2025.
Abstract Aims The prevalence of diabetes and obesity continues to rise in women of reproductive age, with significant implications for both mother and foetus. Glucagon‐like peptide‐1 receptor agonists are effective treatments of diabetes and obesity. However, no Glucagon‐like peptide‐1 receptor agonists are currently approved for use during pregnancy ...
Claire H. Parker, Craig Slattery, Donal J. Brennan, Carel W. le Roux   +3 more
wiley   +1 more source

Neonatal Cholestasis Associated With Transient Congenital Hyperinsulinism: A Case Report. [PDF]

Cureus
Ibi K, Shitara Y, Adachi N, Tanaka H, Takahashi N.   +4 more
europepmc   +1 more source

Total Parenteral Nutrition-Associated Cholestasis

, 1986
Zvi Gimmon
openalex   +1 more source

Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases

Liver International, Volume 45, Issue 8, August 2025.
ABSTRACT Background and Aims Autoimmune liver diseases (AILD), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), can lead to progressive liver fibrosis, development of cirrhosis, decompensation, hepatocellular carcinoma (HCC), and need for liver transplantation (LT).
Ellina Lytvyak, Gideon Hirschfield, Devika Shreekumar, Yu Jun Wong, Aldo J. Montano‐Loza   +4 more
wiley   +1 more source

Hepatitis E virus infection-triggered intrahepatic cholestasis: A case report. [PDF]

World J Hepatol
Drexler S, Haedge F, Weber SN, Krawczyk M, Matter MS, Geppert CI, Weber A, Stieger B, Trautwein C, Kremer AE.   +9 more
europepmc   +1 more source